Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142595 |
| CAS No | NA |
| Mol.F. | C16H26N2O4 |
| Mol.Wt. | 310.39 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142596 |
| CAS No | NA |
| Mol.F. | C13H20N2O4 |
| Mol.Wt. | 268.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142597 |
| CAS No | NA |
| Mol.F. | C19H29N3O5 |
| Mol.Wt. | 379.46 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142598 |
| CAS No | NA |
| Mol.F. | C11H15N3O4 |
| Mol.Wt. | 253.26 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142599 |
| CAS No | NA |
| Mol.F. | C12H13N3O5 |
| Mol.Wt. | 279.25 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142600 |
| CAS No | NA |
| Mol.F. | C18H27N3O3 |
| Mol.Wt. | 333.43 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142601 |
| CAS No | NA |
| Mol.F. | C19H31N3O4 |
| Mol.Wt. | 365.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142602 |
| CAS No | NA |
| Mol.F. | C22H36N2O9 |
| Mol.Wt. | 472.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142603 |
| CAS No | NA |
| Mol.F. | C8H11N3O2 |
| Mol.Wt. | 181.20 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142604 |
| CAS No | NA |
| Mol.F. | C15H19N4O |
| Mol.Wt. | 271.34 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142605 |
| CAS No | NA |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.21 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142606 |
| CAS No | NA |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142607 |
| CAS No | 151512-14-0 |
| Mol.F. | C6H12N4O3 |
| Mol.Wt. | 188.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142608 |
| CAS No | NA |
| Mol.F. | C32H45N5O4 |
| Mol.Wt. | 563.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142609 |
| CAS No | NA |
| Mol.F. | C24H26N4O4 |
| Mol.Wt. | 434.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142610 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |